Skip to main content
Journal of Clinical and Diagnostic Research : JCDR logoLink to Journal of Clinical and Diagnostic Research : JCDR
. 2014 Nov 20;8(11):DC25–DC27. doi: 10.7860/JCDR/2014/11105.5212

Evaluation of Chromogenic Media in Detection of Vancomycin Resistant Enterococci

Vijaya D 1,, Vijaya S 2, Santhya ST 3, Yashaswini MK 4, Megha S 5
PMCID: PMC4290239  PMID: 25584221

Abstract

Introduction: Vancomycin resistant Enterococci have become important nosocomial pathogens. So it is necessary to monitor continuously such infections in the hospitals.

Materials and Methods: A total of 100 Enterococci isolated from 4489 various clinical samples were speciated and antibiogram was done according to standard laboratory methods. The efficacy of CHROMagarTM VRE (France) and Hicrome VRE (Himedia) in detecting VRE was evaluated using E- test (Himedia).

Results: Hicrome VRE and CHROMagarTM VRE showed sensitivity of 100% and specificity of 99% as compared to E-test.

Conclusion: In the present study VRE was not isolated. Prudent use of vancomycin and continuous surveillance for VRE will prevent the emergence of vancomycin resistant Enterococci in the locality in future. Identification of VRE by chromogenic media is rapid, easy to perform, cost effective compared to technically demanding, time consuming and costly conventional method.

Keywords: CHROMagarTM, E-test, Hicrome VRE, Vancomycin resistant Enterococci

Introduction

Enterococci form the part of the normal flora in both the human and animal gastrointestinal tracts. These organisms have become notorious nosocomial pathogens, in spite of their limited virulence. This is related to their resistance to several antimicrobial agents and this resistance can be intrinsic (low level to penicillin, cephalosporins and aminoglycoside) as well as acquired resistance to glycopeptides with high level resistance to aminoglycoside. Vancomycin resistant Enterococci (VRE) was reported in 1988 by Uttley [1]. The first report of vancomycin resistant Enterococci (VRE) in India was done by Mathur in 1999, from New Delhi [2]. Later, various authors have reported prevalence of 1– 8.7% of VRE in India [35].

Many reports are available in the literature regarding the identification of vancomycin-resistant Enterococci (VRE) using conventional microbiological methods, which require time, resource and space. These standard methods are labour-intensive and require 48-72 h to give the result. Therefore, management of VRE infection relies on rapid and sensitive detection [6].

Chromogenic media are increasingly used as versatile tools in early differentiation and identification of VRE from clinical samples [7]. The present study was undertaken to evaluate the two different chromogenic media, CHROMagarTM VRE (France) and Hicrome VRE (Himedia, India) in detecting VRE in comparison with E- test (Himedia, India).

Materials and Methods

The present study was carried out in the Department of Microbiology, Adichunchanagiri Institute of Medical Sciences, BG Nagara from June 2013 to May 2014. The ethical committee of the institution granted approval for the study. Out of 4489 clinical samples screened, 100 were Enterococci. Isolates were identified and speciated. Further confirmation was done using Group D anti-sera (Histrep, Himedia India) and CHROMagarTM orientation agar (CHROMagar France).

The minimum inhibitory concentration (MIC) for vancomycin is determined by E-test as shown in [Table/Fig-1] (0.016-256 μg/ml). The MIC ≥ 32μg/ml is considered as VRE based on the CLSI guidelines [8].

[Table/Fig-1]:

[Table/Fig-1]:

Vancomycin E-test showing MIC of Enterococci

CHROMagarTMVRE and Hicrome VRE were inoculated and incubated aerobically at 37°C. After 48 h of incubation, growth of Enterococci on these chromogenic media indicates VRE. On CHROMagarTMVRE, used for the detection of Van A and Van B type transmissible resistance; vancomycin resistant E.faecalis/E.faecium produce pink to mauve coloured colonies, E.gallinarum and E.casseliflavus resistant to vancomycin produced blue coloured colonies and other Enterococci were inhibited [Table/Fig-2]. On Hicrome VRE agar, vancomycin resistant E.faecalis produced bluish green colonies and others were inhibited [Table/Fig-3].

[Table/Fig-2]:

[Table/Fig-2]:

CHROMagarTM showing VRE positive control and negative isolate

[Table/Fig-3]:

[Table/Fig-3]:

Hicrome VRE showing VRE positive control and negative isolate.

E.faecalis ATCC 29212 and E.faecalis ATCC 51299 were used as susceptible and resistant control strains respectively. Identification of VRE by E- test was considered as reference method.

Results

Out of 4489 clinical samples studied, 100 (2.2%) Enterococci were isolated. [Table/Fig-4]: shows the prevalence of Enterococci in relation to age and sex. [Table/Fig-5]: shows the distribution of Enterococcus species among the various clinical samples. [Table/Fig-6]: shows the antibiotic susceptibility pattern of Enterococci by KBDDM (%). [Table/Fig-7]: shows the Vancomycin MIC range of Enterococci. [Table/Fig-8]: shows the analysis of Chromogenic media with E-test. [Table/Fig-9]: Shows study of VRE as reported by various workers.

[Table/Fig-4]:

Prevalence of Enterococci in relation to age and sex

Age Years No of Enteroocci Male Female
0-20 10 7 3
21-40 44 15 29
41-60 29 12 17
≥ 61 17 9 8
Total 100 43 57

[Table/Fig-5]:

Enterococci species isolated in relation to various clinical samples

Specimen Total no E.faecalis E.faecium E.gallinarum Enterococci (%)
Urine 1682 31 28 4 63(3.75)
Exudates 716 15 7 0 22(3.07)
Sputum 434 3 2 1 6(1.39)
Blood 943 1 3 0 4(0.42)
Vaginal swab 570 2 1 0 3(1.05)
Body fluids 144 1 1 0 2(1.39)
Total 4489 53 42 5 100(2.2)

[Table/Fig-6]:

Antibiotic susceptibility pattern of Enterococci by KBDDM (%)

Species Ampicillin Penicillin Ciprofloxacin Piperacillin Gentamicin 120 μg Vancomycin Lenozolid Teicoplanin
E.faecalis No.53 64.2 39.4 22.64 45.28 41.51 79.25 100 66.04
E.faecium No.42 52.4 23.8 23.8 40.48 47.62 11.43 100 59.52
E.gallinarum No.05 100 80 00 60 60 40 100 80
100 61 35 22 44 45 74 100 64

[Table/Fig-7]:

Vancomycin MIC range of Enterococci isolates.

MIC range μg/ml E.faecalis E.faecium E.gallinarum Total (%)
≤ 1 20 26 2 48
>1-2 27 13 3 43
>2-4 06 3 0 09
>4-256 0 0 0 0
Total 53 42 05 100

[Table/Fig-8]:

Analysis of Chromogenic media with E-test

Test Positive True positives False positives False negatives True negatives Sensitivity % Specificity%
HiChrome agar 1 0 1 0 99 100 99
CHRO MagarTM 1 0 1 0 99 100 99

[Table/Fig-9]:

Study of VRE as reported by various workers

Enterococci studied VRE % E.faecalis % E.faecium % Others %
Vijaya D 100 0 0 0 0
Padmashini [15] 43 4.6% 72.8% 16.3% 6.9%
Vidyalakshmi [16] 600 4 0 100 0
Baragundi Mahesh [11] 120 7.5 22.2 44.44 33.33
Gupta [17] 100 2 50 50 0
Neelam Taneja [3] 144 5.55 12.5 62.5 25
Purva Mathur [2] 444 1.12 100 0 0

Discussion

Enterococci have attracted much attention in the recent times due to their increased recognition as a cause of nosocomial “super-infection” in patients receiving antimicrobial agents. Enterococci have clearly emerged as a medically important organism in outbreaks of many nosocomial infections. An organism once considered a harmless commensal residing in the intestine has emerged as a multiple drug resistant, virulent pathogen accounting for more hospital borne infection [9].

Enterococci were isolated in 2.22% of the total specimen screened whereas Sreeja reported 0.23% [10]. In India, incidence of Enterococcal infection is not thoroughly identified. E. faecalis is the most prevalent species cultured from humans accounting for 80-90% of clinical isolates in other studies [11].

In the present study, maximum number of Enterococci were isolated from urine samples (3.75%) which is higher than Taneja (1.5%) [3] and Sreeja (1.58%) [10]. Enterococci were isolated from 3.07% of exudates and 0.42% of blood, whereas Sreeja has a higher rate of isolation from exudates (4.47%) and blood (1.1%) [10].

In the present study, E.faecalis were isolated more (53%), which is in comparison with other studies [3,6,11,12].

In the present study, E. faecalis and E. faecium showed almost similar sensitivity to various antibiotics by KBDDM. Resistance to various antibiotics among clinical strains of Enterococci species is a progressive and widely spreading problem. In the present study 55% of the isolate showed high level gentamycin resistance. Similar finding was found in Goshal, whereas Agarwal has reported 7.8% [12,13]. The higher rate of resistance in the present study is attributed to wider usage of broad spectrum antibiotics as this Hospital being a tertiary care Centre.

In the present study, 100% isolates were sensitive to linezolid is in comparison with the report of Gupta and Padmasini [14,15]. Linezolid was the first oxazolidinone to be available for clinical use in 2000. It has activity against both E. faecium and E. faecalis. Another advantage is that it can be administered both intravenously and orally [5]. The pattern of teicoplanin sensitivity in this study correlated with Gupta by disc diffusion method [14].

Vancomycin showed 26% of resistance by KBDDM as shown in the [Table/Fig-4]. By E-test, all Enterococci were sensitive to Vancomycin with MIC <4μg/ml. This proves the inaccuracy of KBDDM in detecting the susceptibility to vancomycin. Others have reported varying percentage of VRE in their studies which is shown in the [Table/Fig-9] [2,3,1417].

Risk factor for VRE is from exposure to VRE positive patients and lengthy hospital stay. Organ transplantation and hemodialysis patients form the high risk groups, mostly by stool of patient contaminating the environment. Outbreak of VRE can occur from fabric sheets and transferred by staffs’ hands. Vancomycin resistant Enterococci have been shown to be capable of surviving on dry surfaces in the hospital for upto four months [18].

In the present study, CHROMagarTM VRE and Hicrome VRE showed sensitivity of 100% and specificity of 99%, whereas, Llacsahuanga reported sensitivity of 98.2% and specificity of 96.5% and Hajia reported 100% sensitivity and specificity for CHROMagarTMVRE correlating with the present study [7,19]. Jenkins showed sensitivity and specificity of 98% and 95% respectively using a different Chromogenic media [20].

Conventional E-test relies on isolation of the organisms as a first step, then identification of its resistance to the vancomycin on 3rd or 4th day. Therefore, rapid, sensitive and inexpensive methods for detection of VRE are needed. Chromogenic media incorporating Chromogenic enzyme substrates and antimicrobial agents have become available for detection of VRE. E-test cannot be performed directly on clinical specimens, whereas Chromogenic media can be used. Another advantage of CHROMagar, is it can be used for routine screening and identification of VRE in hospitalized patients, thereby routine surveillance will prevent the spread of VRE among patients [7].

Advantage of chromogenic media is that it is rapid, simple, easy to perform, cost effective compared to time consuming, laborious and technically demanding conventional method.

Conclusion

Enterococcus infection should be of concern for health care institution. The early detection of VRE will help in the effective therapy and infection control measures, to prevent the spread of VRE. Chromogenic media has higher sensitivity and specificity in the detection of VRE and can be incorporated in the routine screening. The present study indicates that Chrom agar (Hicrome & CHROMagarTMVRE) in detection of VRE is simple, rapid, easy to perform and cost-effective compared to conventional E- test.

Acknowledgments

“We thank the CHROMAGAR Paris- France company for the free supply of CHROMagarTM VRE. Authors are grateful to president Poojya guru Sri Nirmalananda Swamiji, trustees Dr. Devraj D and Dr Sunil M. We are thankful to Dr.Shivaramu MG, Principal and Dr.Manohar T, Superintendent, AIMS, BG Nagara for the encouragement.” The Media was provided free of cost.

Financial or Other Competing Interests

None.

References

  • [1].Uttley AHC, Collins CH, Naidoo J, George RC. Vancomycin resistant Enterococci. Lancet. 1988;1:57–58. doi: 10.1016/s0140-6736(88)91037-9. [DOI] [PubMed] [Google Scholar]
  • [2].Mathur P, Kapil A, Chandra R, Sharma P, Das B. Antimicrobial resistance in Enterococcus faecalis at a tertiary care centre of Northern India. Indian J Med Res. 2003;118:25–28. [PubMed] [Google Scholar]
  • [3].Taneja N, Rani P, Emmanuel R, Sharma M. Significance of vancomycin resistant Enterococci from urinary specimens at a tertiary care center in Northern India. Indian J Med Res. 2004;119:72–74. [PubMed] [Google Scholar]
  • [4].Kaur N, Chaudhary U, Aggarwal R, Bala K. Emergence of VRE and their antimicrobial sensitivity pattern in a tertiary care teaching hospital. J Med Biol Sci. 2009;8:26–32. [Google Scholar]
  • [5].Praharaj IS, Sujath, Subhash CP. Phenotypic and genotypic characterization of vancomycin resistant Enterococcus isolates from clinical specimens. Indian J Med Res. 2013;138:549–56. [PMC free article] [PubMed] [Google Scholar]
  • [6].Tripathi A, Shukla SK, Singh A, Prasad KN. A new approach of real time polymerase chain reaction in the detection of vancomycin resistant Enterococci in detection of vancomycin resistant Enterococci and its comparison with other methods. Indian J Med Microbiol. 2013;31(1):47–52. doi: 10.4103/0255-0857.108721. [DOI] [PubMed] [Google Scholar]
  • [7].Hajia M, Rahbar M, Zadeh MM. A novel method “CHROMagar” for screening vancomycin – resistant Enterococci (VRE) isolates. African J Biotech. 2012;11(41):9865–68. [Google Scholar]
  • [8].Clinical and Laboratory Standards Institute. Performance standards for Antimicrobial susceptibility supplement testing. Twenty third informational supplement. 2013;M100(33):1. [Google Scholar]
  • [9].Giridhara PM, Ravikumar KL, Umapathy BL. Review of virulence factors of Enterococcus: An emerging nosocomial pathogen. Indian J Med Microbiol. 2009;27(4):301–05. doi: 10.4103/0255-0857.55437. [DOI] [PubMed] [Google Scholar]
  • [10].Sreeja S, Babu PRS, Prathab AG. The Prevalence and the characterization of the Enterococcus species from various clinical samples in a tertiary care hospital. J Clin Diag Res. 2012;6(9):1486–88. doi: 10.7860/JCDR/2012/4560.2539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Nelson RRS, McGregor KF, Brown AR, Amyes GB, Young HK. Isolation and characterization of glycopeptides resistant enterocci from hospitalized patients over a 30-month period. J Clin Microbiol. 2000;38:2112–16. doi: 10.1128/jcm.38.6.2112-2116.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Ghoshal U, Garg A, Tiwari DP, Ayyagari A. Emerging vancomycin resistance in Enterococci in India. Indian J Pathol Microbiol. 2006;49(4):620–22. [PubMed] [Google Scholar]
  • [13].Agarwal VA, Jain YI, Pathak AA. Concomittant high level resistance to penicillin and aminoglycosides in Enterococci at Nagpur, Central India. Indian J Med Microbiol. 1999;17:85–87. [Google Scholar]
  • [14].Gupta V, Singla N. Speciation and antimicrobial susceptibility pattern of Enterococci from a tertiary health care center of North India. J Clin Diag Res. 2007;1(5):385–89. [Google Scholar]
  • [15].Padmasini E, Padmaraj R, Ramesh RR. Detection of vancomycin resistant Enterococci with vanA genotype in clinical isolates from a tertiary care center. Indian J Med Microbiol. 2014;32(1):89–101. doi: 10.4103/0255-0857.124339. [DOI] [PubMed] [Google Scholar]
  • [16].Mahesh BC, Sonth SB, Solabannavar SS, Chidanand SP, Yemul V. Species prevalence and antimicrobial resistance pattern of Enterococcal isolates in a tertiary health care center. J Clin Diag Res. 2010;(4):3405–09. [Google Scholar]
  • [17].Vidyalakshmi PR, Gopalakrishnan R, Ramasubramanian V, Ghafur KA, Nambi PS, Thirunarayana MA. Clinical, epidemiological and microbiological profile of patients with vancomycin-resistant Enterococci from a Tertiary Care Hospital. J Global Infect Dis. 2012;4(2):137–38. doi: 10.4103/0974-777X.96784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].Ramadhan AA, Hegedus E. Survivability of vancomycin resistant Enterococci and fitness cost of vancomycin resistance acquisition. J Clin Pathol. 2005;58:744–46. doi: 10.1136/jcp.2004.024091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Llacsahuanga HP, Top J, Heynemann JW, Lutticken R, Haase G. Comparison of two Chromogenic media for selective isolation of Vancomycin Resistant Enterococci form stool specimens. J Clin Microbiol. 2009;47(12):4113–16. doi: 10.1128/JCM.00882-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [20].Jenkins SG, Raskoshina L, Schuetz AN. Comparison of performance of the novel Chromogenic spectra VRE agar to that of Bile esculin azide agar and Campylobacter agars for the detection of Vancomycin-Resistant Enterococci in fecal samples. J Clin Microbiol. 2011;49(11):3947–49. doi: 10.1128/JCM.00180-11. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical and Diagnostic Research : JCDR are provided here courtesy of JCDR Research & Publications Private Limited

RESOURCES